Bio hyurim fat-derived stem cell therapy (Hurim Biocell)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameBio hyurim fat-derived stem cell therapy (Hurim Biocell)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEndocrine System DiseasesCardiomyopathiesCartilage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHurim Biocell Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHurim Biocell Inc
Active IndicationsN/A
Inactive IndicationsEndocrine System DiseasesCardiomyopathiesCartilage Diseases

Other Information

ATC CodeN/A
Related LinksN/A